Brightgene Bio-medical Technology Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is FIDAXOMICIN CRYSTALLINE, with a corresponding US DMF Number 28803.
Remarkably, this DMF maintains an Active status since its submission on November 26, 2014, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 25, 2015, and payment made on November 24, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II